@inproceedings{inproceedings, title  = {{Radium-223(Ra-223) safety and efficacy in prostate cancer with bone metastases: phase 3 ALSYMPCA study findings stratified by age}},

 url = {{}},

 year = {{2013}},

 month = {{8}},

 author = {{Sartor O and Coleman R and Nilsson S and Heinrich D and Staudacher K and Garcia-Vargas J and Vogelzang N}},

 volume = {{112}},

 journal = {{BJU INTERNATIONAL}},

 pages = {{15-16}},

 note = {{Accessed on 2025/10/10}}}